dalteparin has been researched along with Cerebrovascular Disorders in 7 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Acute cerebral ischemia was discovered to be the most common cerebrovascular disease associated with SARS-CoV-2." | 1.72 | Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies? ( Ates, O; Dogan, M; Ersoz, E; Hacioglu Kasim, FB; Karaarslan, N; Ozbek, H; Yilmaz, I, 2022) |
| "Inflammatory bowel diseases (IBD)--ulcerative colitis and Crohn's disease--are associated with increased risk for thrombotic complications both in the arterial and venous system." | 1.32 | [Cerebral sinus thrombosis and ulcerative colitis: two cases]. ( Debreczeni, R; Ilniczky, S; Kovács, T; Szirmai, I, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Ilniczky, S | 1 |
| Debreczeni, R | 1 |
| Kovács, T | 1 |
| Szirmai, I | 1 |
| Kay, R | 2 |
| Wong, KS | 2 |
| Yu, YL | 1 |
| Chan, YW | 1 |
| Tsoi, TH | 1 |
| Ahuja, AT | 1 |
| Chan, FL | 1 |
| Fong, KY | 1 |
| Law, CB | 1 |
| Wong, A | 1 |
| Biller, J | 1 |
| Sherman, DG | 1 |
| Ates, O | 1 |
| Yilmaz, I | 1 |
| Karaarslan, N | 1 |
| Ersoz, E | 1 |
| Hacioglu Kasim, FB | 1 |
| Dogan, M | 1 |
| Ozbek, H | 1 |
| Bertini, G | 1 |
| Perugi, S | 1 |
| Dani, C | 1 |
| Prisco, D | 1 |
| Fonda, C | 1 |
2 reviews available for dalteparin and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Indication and management of anticoagulants in cerebrovascular disease].
Topics: Anticoagulants; Cerebrovascular Disorders; Heparin; Humans; Nadroparin | 1997 |
Heparin and heparinoids in stroke.
Topics: Anticoagulants; Cerebrovascular Disorders; Heparin; Humans; Nadroparin; Randomized Controlled Trials | 1998 |
1 trial available for dalteparin and Cerebrovascular Disorders
| Article | Year |
|---|---|
Low-molecular-weight heparin for the treatment of acute ischemic stroke.
Topics: Activities of Daily Living; Acute Disease; Aged; Brain Ischemia; Cerebral Hemorrhage; Cerebral Infar | 1995 |
4 other studies available for dalteparin and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Cerebral sinus thrombosis and ulcerative colitis: two cases].
Topics: Adult; Anticoagulants; Cerebrovascular Disorders; Colitis, Ulcerative; Female; Humans; Magnetic Reso | 2003 |
Low-molecular-weight heparin and serum potassium.
Topics: Anticoagulants; Brain Ischemia; Cerebrovascular Disorders; Humans; Nadroparin; Potassium | 1997 |
Coexistence of SARS-CoV-2 and cerebrovascular diseases: does COVID-19 positivity trigger cerebrovascular pathologies?
Topics: Aspirin; Brain Ischemia; Cerebrovascular Disorders; Clopidogrel; COVID-19; Enoxaparin; Humans; Manni | 2022 |
Cerebral venous thrombosis treated with enoxaparin in an IUGR neonate with DIC.
Topics: Anticoagulants; Brain; Cerebral Hemorrhage; Cerebral Veins; Cerebrovascular Disorders; Disseminated | 2009 |